awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28072765-36EAE4F6-0C24-48F9-A6B8-37F80C095742
Q28072765-36EAE4F6-0C24-48F9-A6B8-37F80C095742
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072765-36EAE4F6-0C24-48F9-A6B8-37F80C095742
Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects
P2860
Q28072765-36EAE4F6-0C24-48F9-A6B8-37F80C095742
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072765-36EAE4F6-0C24-48F9-A6B8-37F80C095742
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc759297800c3167a7a41fdff880abc0ed2cf732
P2860
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models.